PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics

PhaseBio Pharmaceuticals, Inc. (PHAS): $0.07

0.02 (-26.21%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add PHAS to Watchlist
Sign Up

PHAS Price/Volume Stats

Current price $0.07 52-week high $4.08
Prev. close $0.10 52-week low $0.07
Day low $0.07 Volume 9,647,400
Day high $0.09 Avg. volume 848,888
50-day MA $0.58 Dividend yield N/A
200-day MA $1.01 Market Cap 3.50M

PHAS Stock Price Chart Interactive Chart >


PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.


PHAS Latest News Stream


Event/Time News Detail
Loading, please wait...

PHAS Latest Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -98.30%
5-year -97.74%
YTD N/A
2023 N/A
2022 0.00%
2021 -22.32%
2020 -45.01%
2019 97.73%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!